Maven Securities LTD Bluebird Bio, Inc. Transaction History

Maven Securities LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$3.14 - $8.22 $785,000 - $2.06 Million	250,000 New	250,000 $795,000
Q3 2020 Nov 13, 2020	SELL	$34.44 - $43.75 $6.89 Million - $8.75 Million	-200,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$27.12 - $45.97 $5.42 Million - $9.19 Million	200,000 New	200,000 $12.2 Million
Q1 2020 May 15, 2020	SELL	$26.16 - $63.5 $1.5 Million - $3.64 Million	-57,265 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$46.96 - $61.67 $2.69 Million - $3.53 Million	57,265 New	57,265 $5.07 Million
Q2 2018 Aug 13, 2018	SELL	$99.64 - $127.59 $298,920 - $382,770	-3,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$105.8 - $150.94 $317,400 - $452,820	3,000 New	3,000 $512,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $28.5M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.